期刊文献+

冠心病患者血浆同型半胱氨酸的变化及其机制的探讨 被引量:52

The mechanisms of hyperhomocysteinemia in coronary heart disease
原文传递
导出
摘要 目的探讨同型半胱氨酸(HCY)及其代谢相关因子和血脂与冠心病发病之间的关系。方法40例经冠状动脉造影术证实为正常或冠心病患者,应用高效液相色谱分析测定血浆HCY,同时测定血浆叶酸、维生素B12浓度及血脂水平,并应用PCR检测N5,N10亚甲基四氢叶酸还原酶(MTHFR)基因型。结果(1)冠心病患者血浆HCY浓度(171±36μmol/L)高于正常对照组(76±12μmol/L),合并有心肌梗死、高血压和有冠心病家族史的患者,其血浆HCY浓度更高;(2)血浆HCY浓度与血浆叶酸、维生素B12浓度呈明显的非线性相关;(3)MTHFR纯合子突变者,血浆HCY浓度高;(4)CHD患者血脂与HCY水平无明显相关。结论高同型半胱氨酸血症是冠心病的新的独立危险因素。 Objective To identify hyperhomocysteinemia (HHe) as a new and independent risk factor for coronary heart disease (CHD). Methods The association of coronary heart disease (CHD) and lipid, homocysteine (HCY) and the factors related to its metabolisms were examined. The mutation of the 677C→T transition of MTHFR was determined by PCR based assay. Whole blood and plasma folate (FA) and plasma vitamin B 12 (B 12 ), as cofactors of those enzymes, were determined by radioimmunologic assay. Plasma HCY was determined by HPLC. Results Patients with CHD confirmed by coronary angiography had increased plasma HCY concentrations (17.1±3.6 μmol/L、7 6±1.2 μmol/L). In patients with MI, HPT and family history (FH) of CHD, plasma HCY increased significantly. Plasma HCY concentrations had significant non linear inverse relation with plasma FA and B 12 concentrations. Homozygous mutants showed higher plasma HCY concentrations. Patients with CHD had increased serum CHOL and VLDL levels, but plasma HCY concentrations were not correlated with serum lipid levels. Conclusion Hyperhomocysteinemia is an independent risk factor for coronary heart disease.
出处 《中华医学杂志》 CAS CSCD 北大核心 1998年第11期821-823,共3页 National Medical Journal of China
基金 国家攀登计划资助
关键词 冠心病 血浆 半胱氨酸 Coronary disease Homocysteine
  • 相关文献

同被引文献323

引证文献52

二级引证文献328

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部